Form 8-K Synthetic Biologics, For: May 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq on track for record closing highs as focus turns to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Synthetic Biologics (SYN) Misses Q1 EPS by 9c
May 11, 2015 4:42 PM EDTSynthetic Biologics (NYSE: SYN) reported Q1 EPS of ($0.17), $0.09 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.
... More


